-
Jan 242025One injection per month, effective for 2 years! Monoclonal antibody therapy r...
Recently, Anthos Therapeutics announced that the positive results obtained from the Phase 2 clinical trial of AZALEA-TIMI 71 using its Factor XI targe
-
Jan 222025Take a puff to relieve depression! The efficacy lasts for one month, and the ...
Johnson&Johnson announced today that the US FDA has approved its Spravato (esketamine) nasal spray to treat adult patients with refractory depression
-
Jan 212025Over 500 million US dollars! Another bispecific antibody has been authorized,...
InnoCare Pharma and KeyMed Biosciences announced today that they have reached an exclusive licensing agreement with Prolium Bioscience to jointly deve
-
Jan 202025The disease control rate exceeds 85%! New drug treatment for lung cancer has ...
KRAS mutation is one of the most common driver gene mutations in non-small cell lung cancer (NSCLC). KRAS was once considered a "difficult to dru
-
Jan 162025Esters undergo reductive amination! Top issue Angew report, AMAZING!
Carbon nitrogen construction is a classic reaction in organic synthesis, with various construction methods such as Buchwald coupling, Ullman coupling,
-
Jan 11202511 new drugs that may become heavyweight in the next five years!
Recently, Clarivate, a well-known institution in the industry, released its latest Drugs to Watch ™ report In the report, the institution identified 1
-
Jan 102025The therapeutic effect lasts up to 8 hours! The application for the marketing...
Today, Tenpoint Therapeutics announced the positive top line results of its second phase 3 key trial, BRIO-II. Analysis shows that the trial achieved
-
Jan 072025AI pharmaceuticals: new insights in the boom
The field of artificial intelligence (AI) is a highly anticipated area in 2024. The 2024 Nobel Prize in Physics was awarded to the scientists who laid
-
Jan 032025Over 1 billion US dollars! Roche achieves potential 'best in class' anti-canc...
Innovent Biologics announced a global exclusive cooperation and licensing agreement with Roche to advance the development of IBI3009, a candidate prod
-
Jan 022025Three innovative drugs expected to receive FDA approval in January
According to the expected target date of PDUFA, it is expected that by January 2025, the US FDA will make regulatory decisions on the approval of thre
-
Dec 312024Sangamo drops 60%: Pfizer returns gene therapy for hemophilia A
On December 30, 2024, Sangamo Therapeutics announced Pfizer's return of global rights to gene therapy for hemophilia A, and Pfizer stated that it will
-
Dec 302024The world's first batch! Potential blockbuster ADC approved to treat breast c...
Daiichi Sankyo announced today that the antibody coupling drug (ADC) Datoway (datopotamab deruxtecan) jointly developed by the company and AstraZeneca

